Insider Transactions in Q4 2022 at Krystal Biotech, Inc. (KRYS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
8,012
-0.23%
|
$640,960
$80.7 P/Share
|
|
Dec 29
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
8,010
-0.23%
|
$640,800
$80.7 P/Share
|
|
Dec 29
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
8,010
-0.23%
|
$640,800
$80.7 P/Share
|
|
Dec 29
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
8,012
-0.23%
|
$640,960
$80.7 P/Share
|
|
Dec 16
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
10,527
-0.61%
|
$842,160
$80.1 P/Share
|
|
Dec 16
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
10,572
-0.59%
|
$845,760
$80.1 P/Share
|
|
Dec 16
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
10,572
-0.59%
|
$845,760
$80.1 P/Share
|
|
Dec 16
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
10,527
-0.61%
|
$842,160
$80.1 P/Share
|
|
Nov 23
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
4
-0.0%
|
$320
$80.01 P/Share
|
|
Nov 23
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
4
-0.0%
|
$320
$80.01 P/Share
|
|
Nov 08
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
823
-0.05%
|
$65,840
$80.04 P/Share
|
|
Nov 08
2022
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
966
-0.05%
|
$77,280
$80.05 P/Share
|
|
Nov 08
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
966
-0.05%
|
$77,280
$80.05 P/Share
|
|
Nov 08
2022
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
823
-0.05%
|
$65,840
$80.04 P/Share
|